TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $191 | -99.9% | 12,164 | +13.5% | 0.02% | +15.4% |
| Q3 2022 | $139,000 | -4.1% | 10,719 | +6.1% | 0.01% | +18.2% |
| Q1 2022 | $145,000 | -4.6% | 10,105 | -9.3% | 0.01% | -31.2% |
| Q4 2021 | $152,000 | -71.7% | 11,135 | -66.1% | 0.02% | -66.0% |
| Q3 2021 | $538,000 | +63.5% | 32,857 | +68.1% | 0.05% | +46.9% |
| Q2 2021 | $329,000 | +2.8% | 19,551 | +11.7% | 0.03% | +39.1% |
| Q1 2021 | $320,000 | +61.6% | 17,509 | +51.9% | 0.02% | +53.3% |
| Q3 2019 | $198,000 | -7.0% | 11,527 | -4.3% | 0.02% | +25.0% |
| Q2 2019 | $213,000 | – | 12,051 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |